O
MGTX icon

OrbiMed’s MeiraGTx Holdings MGTX Stock Holding History

OrbiMed’s Portfolio MGTX Stock Details MGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,108,143
Closed -$17.7K – 126
2022
Q3 		$17.7K Sell
2,108,143
-393,475
-16% -$3.47M 0.33% 68
2022
Q2 		$18.9K Sell
2,501,618
-795,048
-24% -$7.71M 0.34% 64
2022
Q1 		$45.7M Sell
3,296,666
-430,800
-12% -$6.63M 0.74% 41
2021
Q4 		$88.5M Sell
3,727,466
-375,459
-9% -$7.19M 1.14% 32
2021
Q3 		$54.1M Hold
4,102,925
– – 0.59% 50
2021
Q2 		$63.6M Hold
4,102,925
– – 0.64% 48
2021
Q1 		$59.2M Hold
4,102,925
– – 0.55% 51
2020
Q4 		$62.1M Buy
4,102,925
+389,105
+10% +$5.5M 0.54% 52
2020
Q3 		$49.2M Hold
3,713,820
– – 0.62% 49
2020
Q2 		$46.5M Buy
3,713,820
+131,500
+4% +$1.83M 0.65% 48
2020
Q1 		$48.1M Buy
3,582,320
+129,300
+4% +$2.18M 0.81% 37
2019
Q4 		$69.1M Buy
3,453,020
+103,960
+3% +$1.78M 0.99% 36
2019
Q3 		$53.4M Buy
3,349,060
+762,109
+29% +$17.7M 1.01% 33
2019
Q2 		$69.5M Buy
2,586,951
+126,700
+5% +$2.62M 1.08% 31
2019
Q1 		$42.4M Buy
2,460,251
+1,990,298
+424% +$28M 0.66% 44
2018
Q4 		$4.53M Buy
469,953
+216,770
+86% +$2.73M 0.08% 102
2018
Q3 		$3.44M Buy
+253,183
New +$2.74M 0.04% 134

Other funds holding MGTX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed's MGTX Position: Q4 2022 in Review

OrbiMed sold out of MeiraGTx Holdings (MGTX) in Q4 2022, closing a stake of 2,108,143 shares — an estimated $17.7K sold.

OrbiMed first reported a position in MGTX in Q3 2018 and held it in 17 quarters. The position peaked at $88.5M in Q4 2021. 99 funds tracked by Wall St. Rank hold MGTX as of Q4 2022.

  • OrbiMed reported no remaining MeiraGTx Holdings position as of Q4 2022 after selling out during the quarter.
  • OrbiMed sold 2,108,143 MeiraGTx Holdings shares in Q4 2022, an estimated $17.7K.
  • OrbiMed first reported a position in MeiraGTx Holdings in Q3 2018 and held it in 17 quarters.
  • OrbiMed's MeiraGTx Holdings position peaked at $88.5M in Q4 2021.
  • 99 funds tracked by Wall St. Rank held MeiraGTx Holdings as of Q4 2022.

Based on OrbiMed's 13F filing for Q4 2022, filed 14 Feb 2023.